'Game-changing' HIV prevention jab to be approved for use in England and Wales

NHS to offer new HIV prevention injection to around 1000 people

It will be available on the NHS for people who cannot have pre-exposure prophylaxis (PrEP) tablets

Every-2-month HIV shot approved in UK, what does it mean for India

A major breakthrough in HIV prevention has just been made in the UK. The National Institute for Health and Care Excellence (NICE) has officially approved a long-acting HIV prevention jab, which needs to be taken just once every two months, instead of a daily pill. Experts are calling it a game-changer in the fight against HIV. The jab, called Cabotegravir Long-Acting (CAB-LA), has been proven to be as effective, or even more so, than daily oral …

New HIV prevention injection rolls out to end new cases by 2030

The injection, known as cabotegravir, is a form of pre-exposure prophylaxis (PrEP) and is administered every two months.

Injectable PrEP is coming to the UK in a groundbreaking development against HIV

Rollout in the NHS is expected to begin within two months in Wales and three months in England, pending appeals The post Injectable PrEP is coming to the UK in a groundbreaking development against HIV appeared first on Attitude.

ViiV's bimonthly HIV PrEP jab cleared for use by NHS

ViiV's injectable HIV PrEP Apretude will soon be an alternative for people in England and Wales who cannot use daily oral options.

England to Get Access to Long-Acting HIV Prevention Drug

England’s drug pricing regulator recommended GSK Plc’s HIV prevention injection, making it the first long-acting pre-exposure treatment for use within the National Health Service.